Showing results (1-10 of 169) with videos related to
Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|May 28, 2016
Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?Sarah J Welsh, Helen Rizos, Richard A Scolyer, et al.International Journal of Molecular Sciences|September 30, 2020
Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to TherapyElena Shklovskaya, Helen RizosInternational Journal of Molecular Sciences|July 2, 2021
MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome ItElena Shklovskaya, Helen RizosMammalian Genome : Official Journal of the International Mammalian Genome Society|July 4, 2018
Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanismsSu Yin Lim, Helen RizosEbiomedicine|January 19, 2024
Single-cell RNA sequencing in melanoma: what have we learned so far?Su Yin Lim, Helen RizosMethods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Monitoring oncogenic B-RAF-induced senescence in melanocytesSieu L Tran, Helen RizosBiochemical and Biophysical Research Communications|August 2, 2011
Differential PAX3 functions in normal skin melanocytes and melanoma cellsSandra Medic, Helen Rizos, Mel ZimanAdvances in Experimental Medicine and Biology|February 16, 2017
The Role of Sumoylation in SenescenceLyndee L Scurr, Sebastian Haferkamp, Helen RizosCell Cycle (Georgetown, Tex.)|February 11, 2005
Enforced expression of p14ARF induces p53-dependent cell cycle arrest but not apoptosisStuart Gallagher, Richard F Kefford, Helen RizosCell Cycle (Georgetown, Tex.)|May 7, 2005
p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partnersHelen Rizos, Sarah Woodruff, Richard F KeffordPageof 17